Novo Nordisk Files for Approval of Oral Weight-Loss Drug Wegovy in China, Challenging Eli Lilly’s Lead — BigGo Finance
Novo Nordisk (NVO.US) announced on the 27th that China’s National Medical Products Administration has accepted its marketing application…